Sign in
4

Changes in Ownership

PRECISION BIOSCIENCES INC Filed Acc 0001209191-21-020273

President and CEO sold 19,421 shares at an average $11.58 ($224,992)

  • President and CEO acquired 43,028 shares (option exercise)

From the SEC's structured data for this filing

Trades in this filing

KANE MATTHEW R. · President and CEO

Table I: Non-derivative

4 lines
Date Transaction Shares Price Value Owned after D/I
2021-03-10 Exercise or conversion : show line 1 in the form +21,514 $0.04 $861 1,915,573 D
2021-03-10 Sale : show line 2 in the form −9,710 $11.79 $114,481 1,905,863 D
2021-03-11 Exercise or conversion : show line 3 in the form +21,514 $0.04 $861 1,927,377 D
2021-03-11 Sale : show line 4 in the form −9,711 $11.38 $110,511 1,917,666 D
Open-market sales · 19,421 sh · avg $11.58 · $224,992

Table II: Derivative

2 lines
Date Transaction Shares Owned after D/I
2021-03-10 Exercise or conversion : show line 5 in the form Employee Stock Option (Right to Buy) −21,514 172,112 D
2021-03-11 Exercise or conversion : show line 6 in the form Employee Stock Option (Right to Buy) −21,514 150,598 D
Loading xslF345X03/doc4.xml…